CD19+ sEV that carried CD39 and CD73 ectoenzymes was shown to sequentially hydrolyze ATP from tumor cells into adenosine, a highly immune-suppressive molecule that inhibits T cell activation, impairing post-chemotherapeutic CD8+ T cell responses. This evidence concerns the gene CD19 and neoplasm.